Navigation Links
Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
Date:6/14/2013

NEW YORK, June 14, 2013 /PRNewswire/ --

Today, Wall Street Reports announced new research reports highlighting Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), and ImmunoGen, Inc. (NASDAQ: IMGN). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Alexion Pharmaceuticals, Inc. Research Report

On June 5, 2013, Alexion Pharmaceuticals, Inc. (Alexion) announced that the results of trials published in The New England Journal of Medicine (NEJM) showed that chronic Soliris (eculizumab) therapy is effective in the treatment of patients with atypical hemolytic uremic syndrome (aHUS), a genetic, life-long, ultra-rare disease associated with vital organ failure and premature death. According to results of two pivotal studies published in the NEJM, chronic Soliris treatment substantially inhibits systemic complement-mediated thrombotic microangiopathy (TMA), decreases the need for TMA-related intervention, and results in significant and sustained improvement in platelet count. It also increasingly improves renal function across patient groups over time, and is associated with substantial kidney recovery in patients with aHUS. Soliris was approved for the treatment of patients with aHUS in the US, Europe, and other countries based on data from the two prospective studies published in NEJM. The Full Research Report on Alexion Pharmaceuticals, Inc. - includin
'/>"/>

SOURCE Wall Street Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
2. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
3. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
4. Oncologix Tech Inc. (OCLG) Acquires Dotolo; Gains Ongoing Sales, Patents, and New CEO
5. Net Medical Xpress Q3 Revenue Up 34% With Ongoing Launch of New Telemedicine Services
6. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
7. Microfabrica To Introduce Educational Series For Design Engineers Challenged With Ongoing Drive To Miniaturization
8. Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH2
9. Tumor Immunotherapy Efficacy Increased in Both Breast and Prostate Cancer Preclinical Models with Addition of Galectin Inhibitor
10. Pfizer Identifies Synexus South African Clinical Research Sites as INSPIRE Sites - First in Africa
11. inVentiv Health Partners With Medikly To Speed Clinical Trials By Accelerating The Recruitment Of Investigators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... MYERS, Fla. , Jan. 23, 2015  Today the ... of Novartis, Bexsero® for the prevention of serogroup ... 25. Bexsero and Pfizer,s vaccine Trumenba®, which received FDA ... helping prevent this devastating disease. "I ...
(Date:1/23/2015)... 23, 2015 A lot of discussion in the medical ... certain illnesses, injuries, or conditions. As medical science advances, doctors ... with ones that they consider to be more cutting edge. ... one textbook method of treatment that stands out as the ...
(Date:1/23/2015)... Jan. 23, 2015  The Partnership to Fight Chronic Disease (PFCD) released ... care leaders and a new study analyzing the impact of increased ... a nationwide coalition working to educate policy makers and the public ... Capitol was focused on how the Iowa ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2No One-Size-Fits-All Remedy for Hernia Correction 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3
... SAN FRANCISCO, Calif., May 10, 2011 Janssen ... Alzheimer,s Immunotherapy Program, Pfizer Inc., is pleased to ... health organization in Alzheimer,s care, support and research, ... Summits Climb for Alzheimer,s: Memories are Everything ...
... Vista Partners announced today that it ... (AMEX: HBP, TSX: HBP) ("the Company") with a twelve ... at Vista Partners stated, "The Company is developing products ... and most advanced, Interferon alpha-2b, is a potent immuno-modulatory ...
Cached Medicine Technology:Alzheimer's Association Salutes Advocate and Mountaineer Now Climbing Everest as Part of The 7 Summits Climb for Alzheimer's 2Alzheimer's Association Salutes Advocate and Mountaineer Now Climbing Everest as Part of The 7 Summits Climb for Alzheimer's 3Alzheimer's Association Salutes Advocate and Mountaineer Now Climbing Everest as Part of The 7 Summits Climb for Alzheimer's 4Vista Partners Initiates Coverage on Helix BioPharma Corporation; Target Price $6.20 2
(Date:1/22/2015)... City, Florida (PRWEB) January 22, 2015 IsoComforter, ... cold therapy machine with patented IsoTube design to treat specific ... has introduced the most progressive and easy to use patented ... treat post-operative and sports related orthopedic and muscle injuries. ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a ... insurance policy . , Some types of vehicles cannot be ... newly released blog post to see if their vehicle qualifies for ... are some of the cars that cannot be covered by a ...
(Date:1/22/2015)... 22, 2015 Step into a macabre ... Science Museum of Virginia. Wicked Plants, the Museum’s latest ... unearths 75 poisonous, carnivorous and diabolical plants inside of ... to uncover the biochemical, physical and neurological processes between ...
Breaking Medicine News(10 mins):Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... “Hi, who’s on ... tone in her voice. A caller named Mary Ellen describes “very swollen legs from ... Maggie McDermott, RN, deadpans in her Irish brogue. “Now Magster, let’s not start right ... ...
... Key ... , ... 19, 2009 -- Key Metric Software has released Duplicate File Detective v3.0, a major ... a number of new features that focus on extending the scalability and ...
... minutes before intercourse significantly postponed orgasm, study finds , THURSDAY, ... first potential treatment for premature ejaculation has proved effective in ... , PSD502 -- which combines the drugs lidocaine and prilocaine ... intercourse. , The study of men in Canada, Poland and ...
... ... its 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies from January 10-13, ... ... will host its 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management ...
... MELVILLE, N.Y., Nov. 19 Long Island IVF, a full ... patients achieve successful pregnancies, is now offering a new program ... treatment. Through this program and a partnership with In Vitro ... amount of money couples pay for their comprehensive treatment plans ...
... Washington State Nurses Association (WSNA), representing more than 1,600 ... press conference today to highlight serious concerns about the safety ... this H1N1 pandemic. In response to numerous reports from ... hospital fully comply with CDC guidelines on H1N1 prevention and ...
Cached Medicine News:Health News:New National Nurse Talk Radio Show Takes Off with Humor, Health, and a Voice for the Patient Advocate 2Health News:New National Nurse Talk Radio Show Takes Off with Humor, Health, and a Voice for the Patient Advocate 3Health News:Duplicate File Detective v3.0 Provides Enterprise-Grade Duplicate File Management 2Health News:Spray May Delay Ejaculation 2Health News:DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategies 2Health News:DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategies 3Health News:Long Island IVF to Offer IVF Financial Share Program, Limiting Costs and Providing Refunds if IVF is Not Successful 2Health News:Respirators and H1N1 Information Distributed to Registered Nurses at Sacred Heart Medical Center Out of Concern for Nurse and Patient Safety 2Health News:Respirators and H1N1 Information Distributed to Registered Nurses at Sacred Heart Medical Center Out of Concern for Nurse and Patient Safety 3
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... ELISA test for Clostridium difficile antigen that ... sensitivity. That means the laboratory can quickly, ... negatives - which can represent up to ... the organism - and be sure that ...
Medicine Products: